TNFSF10 and cancer: Another strategy to utilize TRAIL antitumor activity is to construct the tumor specific antibody-TRAIL fusion proteins in order to selectively amplify interactions of the TRAIL moiety with the DR4 and DR5 receptors expressed on the surface of cancer cells [22, 23].